Showing results (601-610 of 634) with videos related to
Sort By:
Pageof 64
Science (New York, N.Y.)|August 31, 2023
An mTRAN-mRNA interaction mediates mitochondrial translation initiation in plantsHuy Cuong Tran, Vivian Schmitt, Sbatie Lama, et al.Genes, Brain, and Behavior|July 29, 2017
Comprehensive analysis of two Shank3 and the Cacna1c mouse models of autism spectrum disorderP A Kabitzke, D Brunner, D He, et al.The Journal of Cell Biology|June 25, 2026
Sequential changes in calcium transients during M phase regulate cardiomyocyte proliferationHonghai Liu, Niyatie Ammanamanchi, Jocelyn D Mich-Basso, et al.The American Journal of Cardiology|February 24, 2009
Outcome of noncardiac surgery in patients with ventricular assist devicesJosef Stehlik, Devin M Nelson, Abdallah G Kfoury, et al.The Journal of Physiology|January 11, 2019
Impaired chromaffin cell excitability and exocytosis in autistic Timothy syndrome TS2-neo mouse rescued by L-type calcium channel blockersChiara Calorio, Daniela Gavello, Laura Guarina, et al.European Journal of Heart Failure|August 14, 2010
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpointsBenjamin D Horne, Heidi T May, Abdallah G Kfoury, et al.Translational Psychiatry|July 6, 2021
Toll-like receptor 4 methylation grade is linked to depressive symptom severityAnnica J Rasmusson, Maike Gallwitz, Bardia Soltanabadi, et al.Journal of the American College of Cardiology|July 24, 2010
Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heartStavros G Drakos, Abdallah G Kfoury, Elizabeth H Hammond, et al.Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|December 9, 2014
Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspectsSean P McCandless, Ian D Ledford, Nathan O Mason, et al.Stem Cells (Dayton, Ohio)|April 24, 2012
Are therapeutic human mesenchymal stromal cells compatible with human blood?Guido Moll, Ida Rasmusson-Duprez, Lena von Bahr, et al.Pageof 64